Real-time adherence monitoring for HIV antiretroviral therapy

AIDS and Behavior

Volumn 14, Issue 6, 2010, Pages 1340-1346

  Haberer, Jessica E ^a,b,c   Kahane, Josh ^b   Kigozi, Isaac ^d   Emenyonu, Nneka ^a,b,d   Hunt, Peter ^e   Martin, Jeffrey ^e   Bangsberg, David R ^a,b,c,d  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

^b Harvard Initiative for Global Health   (United States)

^c HARVARD UNIVERSITY   (United States)

^d MBARARA UNIVERSITY OF SCIENCE AND TECHNOLOGY   (Uganda)

^e UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Antiretroviral therapy; Real time adherence monitoring; Wireless technology

Indexed keywords

ARTICLE; DRUG MONITORING; ELECTRONICS; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INSTRUMENTATION; METHODOLOGY; PATIENT COMPLIANCE; PILOT STUDY; UGANDA; VIROLOGY;

ANTIRETROVIRAL THERAPY, HIGHLY ACTIVE; DRUG MONITORING; ELECTRONICS; HIV INFECTIONS; HUMANS; MEDICATION ADHERENCE; PILOT PROJECTS; UGANDA;

EID: 79952277560     PISSN: 10907165     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10461-010-9799-4     Document Type: Article

References (28)

1. Kerr T, Walsh J, Lloyd-Smith E, et al. Measuring adherence to highly active antiretroviral therapy: implications for research and practice. Curr HIV/AIDS Rep. 2005;2(4):200-5.
2. Parienti JJ, Das-Douglas M, Massari V, et al. Not all missed doses are the same: Sustained NNRTI treatment interruptions predict HIV rebound at low-to-moderate adherence levels. PLoS One. 2008;3(7):e2783.
3. Bangsberg DR, Deeks SG. Spending more to save more: interventions to promote adherence. Ann Intern Med. 2010;152(1): 54-6.
4. Boyce JM, Cooper T, Dolan MJ. Evaluation of an electronic device for real-time measurement of alcohol-based hand rub use. Infect Control Hosp Epidemiol. 2009;30(11):1090-5.
5. Walji MF, Coker O, Valenza JA, et al. A persuasive toothbrush to enhance oral hygiene adherence. AMIA Annu Symp Proc. 2008; 1167.
6. United Nations International Telecommunication Union. Measuring the information society -the ICT development index 2009.
7. http://www.itu.int/ITU-D/ict/publications/idi/2009/material/IDI 2009-w5.pdf. Accessed 10 May 2010.
8. Kahn JG, Yang JS, Kahn JS. "Mobile" health needs and opportunities in developing countries. Health Aff. 2010;29(2): 252-8.
9. Schumacher W, Frick E, Kauselmann M, et al. Fully automated quantification of human immunodeficiency virus (HIV) type 1 RNA in human plasma by the COBAS AmpliPrep/COBAS TaqMan system. J Clin Virol. 2007;38(4):304-12.
10. Oyugi JH, Byakika-Tusiime J, Ragland K, et al. Treatment interruptions predict resistance in HIV-positive individuals purchasing fixed-dose combination antiretroviral therapy in Kampala, Uganda. AIDS. 2007;21(8):965-71.
11. Oyugi JH, Byakika-Tusiime J, Charlebois ED, et al. Multiple validated measures of adherence indicate high levels of adherence to generic HIV antiretroviral therapy in a resource-limited setting. J Acquir Immune Defic Syndr. 2004;36(5):1100-2.
12. Byakika-Tusiime J, Crane J, Oyugi JH, et al. Longitudinal antiretroviral adherence in HIV ? Ugandan parents and their children initiating HAART in the MTCT-Plus family treatment model: role of depression in declining adherence over time. AIDS Behav. 2009;13(Suppl 1):82-91.
13. Simoni JM, Kurth AE, Pearson CR, et al. Self-report measures of antiretroviral therapy adherence: A review with recommendations for HIV research and clinical management. AIDS Behav. 2006;10(3):227-45.
14. Hart JE, Jeon CY, Ivers LC, et al. Effect of directly observed therapy for highly active antiretroviral therapy on virologic, immunologic, and adherence outcomes: A meta-analysis and systematic review. J Acquir Immune Defic Syndr. 2010;54(2): 167-79.
15. Amico KR, Harman JJ, Johnson BT, et al. Efficacy of antiretroviral therapy adherence interventions: A research synthesis of trials, 1996 to 2004. J Acquir Immune Defic Syndr. 2006;41(3):285-97.
16. Murtaugh CM, Pezzin LE, McDonald MV, et al. Just-in-time evidence-based e-mail "reminders" in home health care: impact on nurse practices. Health Serv Res. 2005;40(3):849-64.
17. Intille SS. Ubiquitous computing technology for just-in-time motivation of behavior change. Stud Health Technol Inform. 2004;107(Pt 2):1434-7.
18. Holden RJ, Karsh BT. The technology acceptance model: its past and its future in health care. J Biomed Inform. 2010;43(1): 159-72.
19. Davis F. Perceived usefulness, perceived ease of use, and user acceptance of information technology. MIS Q. 1989;13:319-39.
20. Venkatesh V, Morris MG, David GB, et al. User acceptance of information technology: toward a unified view. MIS Q. 2003;27: 425-78.
21. Fishbein M, Ajzen I. Belief, attitude, intention, and behavior: An introduction to theory and research. Reading, MA: Addison-Wesley; 1975.
22. Wendel CS, Mohler MJ, Kroesen K, et al. Barriers to use of electronic adherence monitoring in an HIV clinic. Ann Pharmacother. 2001;35(9):1010-5.
23. Havlir DV, Bassett R, Levitan D, et al. Prevalence and predictive value of intermittent viremia with combination HIV therapy. JAMA. 2001;286(2):171-9.
24. Podsadecki TJ, Vrijens BC, Tousset EP, et al. Decreased adherence to antiretroviral therapy observed prior to transient human immunodeficiency virus type 1 viremia. J Infect Dis. 2007; 196(12):1773-8.
25. Bangsberg DR, Hecht FM, Charlesbois ED, et al. Adherence to protease inhibitors, HIV-1 viral load, and development of drug resistance in an indigent population. AIDS. 2000;14(4):357-66.
26. Bangsberg DR, Perry S, Charlesbois ED, et al. Non-adherence to highly active antiretroviral therapy predicts progression to AIDS. AIDS. 2001;15(9):1181-3.
27. Hogg RS, Heath K, Bangsberg D, et al. Intermittent use of triplecombination therapy is predictive of mortality at baseline and after 1 year of follow-up. AIDS. 2002;16(7):1051-8.
28. Bisson GP, Gross R, Bellamy S, et al. Pharmacy refill adherence compared with CD4 count changes for monitoring HIV-infected adults on antiretroviral therapy. PLoS Med. 2008;5(5):e109.